Targeting the Neurobiology of Restricted and Repetitive Behaviors in Children With Autism Using N-acetylcysteine
Status:
Recruiting
Trial end date:
2023-01-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to target the neurobiology of restricted and repetitive behaviors
in children with autism spectrum disorder using N-acetylcysteine (NAC), a well-tolerated
nutritional supplement that has shown promise for reducing symptom severity in recent
small-scale trials. The findings from this research will shed light on the mechanisms of
action underlying the clinical benefits of NAC.
Phase:
Phase 2
Details
Lead Sponsor:
Stanford University
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)